Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Is Bristol Myers' Deep Pipeline the Key to Future Growth?
Bristol Myers Squibb (BMY) is relying on its robust and promising pipeline to drive future growth, especially as its legacy drugs face generic competition. The company has several key pipeline candidates with multi-billion-dollar potential, including milvexian, admilparant, pumitamig, iberdomide, and mezigdomide, with significant registrational data expected in 2026. BMY is also pursuing label expansions for approved drugs like Sotyktu and Cobenfy.